Navigation Links
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

DUBLIN, Dec. 16, 2013 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering.

Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body.

Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.

This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 - 2018 in terms of value in USD million.

Key Topics Covered:

1 Introduction
1.1 Report description
1.2 Market segmentation
1.3 Scope of the report
1.4 Research methodology
1.5 Assumptions

2 Executive Summary

3 Global Peptide Therapeutics Market Dynamics
3.1 Overview
3.2 Drivers
3.3 Restraints & challenges
3.4 Opportunities
3.5 Porters five forces analysis
3.6 Market attractiveness analysis
3.7 Peptide therapeutics - emerging technologies & trends
3.8 Regulatory policies

4 Global Peptide Therapeutics Market Analysis, By Applications

5 Global Peptide Therapeutics Market, by Route of Administration
5.1 Introduction
5.2 Parenteral Route
5.3 Oral Route
5.4 Pulmonary Route
5.5 Mucosal Route
5.6 Others (Intradermal & Nasal)

6 Peptide Therapeutics Market - Generic & Innovative Segments
6.1 Introduction
6.2 Peptide Therapeutics - Innovative market
6.3 Peptide Therapeutics - Generic market

7 API Peptide Therapeutics Market, In-house Vs CMO
7.1 Introduction
7.2 API peptide therapeutics - In-house market
7.3 Contract Manufacturing Organizations (CMO)

8 Peptide Therapeutics Market, By Technology
8.1 Introduction
8.2 Solid Phase Peptide Synthesis (SPPS)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.4 Hybrid Technology

9 Peptide Therapeutics Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia
9.5 Rest of World

10 Market Share Analysis
10.1 Market share by key players
10.2 Market share by key players in peptide drugs market
10.3 Market share by key players in CMO segment

11 Recommendations
11.1 Success strategies
11.2 Barriers to be considered

12 Company Profiles

Companies Mentioned:

  • Amgen, Inc.
  • Amylin Pharmaceuticals LLC Bristol-Myers Squibb (BMS)
  • AstraZeneca PLC
  • Bachem Holding AG
  • Eli Lilly and Company
  • GlaxoSmithKline (GSK)
  • Ipsen
  • Lonza Inc.
  • Merck & Co.
  • Novartis AG
  • Novo-Nordisk A/S
  • Peptisyntha
  • Pfizer, Inc.
  • PolyPeptide Group.
  • Roche
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals

For more information visit

Media Contact:

Laura Wood , +353-1-481-1716,

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2. Poster & Abstract Entitled 1H-MRS & FDG-PET Studies in the SOD1 G93A - the Use of Stabilized Peptides as a Rationale for Future Treatment in ALS Presented During Annual Northeast ALS Consortium Meeting
3. US Peptides Discusses the Benefit of Human Growth Hormone
4. CEM Wins Peptide Patent Dispute with Biotage
5. Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
7. US Peptides Discusses the Benefit of Human Growth Hormone and IGF-1
8. Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
9. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
10. Tarix Pharmaceuticals Peptide Technology Stimulates Revascularization Following Ischemia
11. US Peptides Discusses IGF 1 in new article series
Post Your Comments:
(Date:10/13/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... Therapy Catapult to advance development of large scale ... immunotherapy. Under the agreement, the Cell Therapy Catapult ... to support advanced clinical trials and eventual commercialization ... --> The Cell Therapy Catapult is a ...
(Date:10/12/2015)... WASHINGTON , Oct. 12, 2015  Former White House ... Press Secretary for the House Narcotics Committee, Robert Weiner ... "Rewriting Drug Policy." The two emphasize that this is now ... Clinton to Jeb Bush , Carly Fiorina ... Sordello cite the newest federal statistics, which they call "a ...
(Date:10/12/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic, and the Dental sectors of healthcare, announced today ... 2015, its guidance for the fourth quarter of 2015, ... Senior Secured Credit Facility. --> ...
Breaking Medicine Technology:
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... To incentivize would-be customers, eMarketing Concepts began a $1 promotion – effectively offering all ... a resounding success, and within weeks the company was flooded with phone calls from ...
(Date:10/13/2015)... ... , ... The Bill Howe Family of Companies is an award winning HVAC ... remediation services. Family-owned and operated for 35 years, they have maintained value, ethics and ... two years in a row from the Union Tribune Reader’s Poll, a Healthiest Company ...
(Date:10/12/2015)... ... 2015 , ... Heroes in Recovery (HIR) is proud to ... Network’s Moments of Change conference in West Palm Beach, Florida. Rob Waggener, CEO ... Dauphinais who exemplify the ideals of the Heroes in Recovery movement. , Noah ...
(Date:10/12/2015)... , ... October 12, 2015 , ... Kevin Costello, winner of the “Check-In and Win ... embarks today for his dream vacation to Hawaii. , “I didn’t believe I could win ... says. “This contest encouraged me to get to the gym and invest in my own ...
(Date:10/12/2015)... ... 12, 2015 , ... The American Society of Clinical Hypnosis ... education and clinical training in a health care discipline. , Many practitioners ... as: losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements and ...
Breaking Medicine News(10 mins):